{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:20:33Z","timestamp":1773019233097,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s10840-016-0126-5","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T01:32:07Z","timestamp":1458523927000},"page":"213-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation"],"prefix":"10.1007","volume":"46","author":[{"given":"Pei-Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong-An","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"issue":"21","key":"126_CR1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Jr., et al. (2014). 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 64(21), e1\u2013e76.","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"126_CR2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.hrthm.2007.04.005","volume":"4","author":"H Calkins","year":"2007","unstructured":"Calkins, H., Brugada, J., Packer, D. L., Cappato, R., Chen, S. A., Crijns, H. J., et al. (2007). HRS\/EHRA\/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm, 4(6), 816\u2013861.","journal-title":"Heart Rhythm"},{"issue":"5","key":"126_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1540-8167.2007.00816.x","volume":"18","author":"A Natale","year":"2007","unstructured":"Natale, A., Raviele, A., Arentz, T., Calkins, H., Chen, S. A., Haissaguerre, M., et al. (2007). Venice chart international consensus document on atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology, 18(5), 560\u2013580.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"126_CR4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijcard.2015.03.376","volume":"187","author":"R Nairooz","year":"2015","unstructured":"Nairooz, R., Sardar, P., Payne, J., Aronow, W. S., & Paydak, H. (2015). Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. International Journal of Cardiology, 187, 426\u2013429.","journal-title":"International Journal of Cardiology"},{"issue":"5","key":"126_CR5","doi-asserted-by":"crossref","first-page":"e0126512","DOI":"10.1371\/journal.pone.0126512","volume":"10","author":"G Santarpia","year":"2015","unstructured":"Santarpia, G., De Rosa, S., Polimeni, A., Giampa, S., Micieli, M., Curcio, A., et al. (2015). Efficacy and safety of non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis. PLoS One, 10(5), e0126512.","journal-title":"PLoS One"},{"issue":"2","key":"126_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10840-015-0053-x","volume":"44","author":"D Lu","year":"2015","unstructured":"Lu, D., Zhang, Q., Liu, Q., Wang, K., Wang, S., & Shan, Q. (2015). Bleeding risks with novel oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and network meta-analysis. Journal of Interventional Cardiac Electrophysiology, 44(2), 105\u2013111.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"key":"126_CR7","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, b2700.","journal-title":"BMJ"},{"issue":"15","key":"126_CR8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, et al. (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA, 283(15), 2008\u20132012.","journal-title":"JAMA"},{"key":"126_CR9","unstructured":"Wells, G., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M., et al. (2014). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp . Accessed 10 June 2015."},{"key":"126_CR10","unstructured":"Higgins, J. P. T., Altman, D. G., & Sterne, J. A. C. (2011). Assessing risk of bias in included studies. In: Higgins, J. P. T., & Green, S. (ed.), Cochrane handbook for systematic reviews of interventions, version 5.1.0. http:\/\/handbook.cochrane.org . Accessed 10 June 2015."},{"issue":"11","key":"126_CR11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/sim.1189","volume":"21","author":"DE Warn","year":"2002","unstructured":"Warn, D. E., Thompson, S. G., & Spiegelhalter, D. J. (2002). Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Statistics in Medicine, 21(11), 1601\u20131623.","journal-title":"Statistics in Medicine"},{"issue":"1","key":"126_CR12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","volume":"3","author":"R Cappato","year":"2010","unstructured":"Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3(1), 32\u201338.","journal-title":"Circulation. Arrhythmia and Electrophysiology"},{"issue":"2","key":"126_CR13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti, G., Ades, A. E., & Ioannidis, J. P. (2011). Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. Journal of Clinical Epidemiology, 64(2), 163\u2013171.","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"126_CR14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ije\/dys222","volume":"42","author":"AA Veroniki","year":"2013","unstructured":"Veroniki, A. A., Vasiliadis, H. S., Higgins, J. P., & Salanti, G. (2013). Evaluation of inconsistency in networks of interventions. International Journal of Epidemiology, 42(1), 332\u2013345.","journal-title":"International Journal of Epidemiology"},{"issue":"7387","key":"126_CR15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","volume":"326","author":"F Song","year":"2003","unstructured":"Song, F., Altman, D. G., Glenny, A. M., & Deeks, J. J. (2003). Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. British Medical Journal, 326(7387), 472.","journal-title":"British Medical Journal"},{"issue":"6","key":"126_CR16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/pace.12401","volume":"37","author":"A Arshad","year":"2014","unstructured":"Arshad, A., Johnson, C. K., Mittal, S., Buch, E., Hamam, I., Tran, T., et al. (2014). Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study. Pacing and Clinical Electrophysiology, 37(6), 665\u2013673.","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"25","key":"126_CR17","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"L Biase Di","year":"2014","unstructured":"Di Biase, L., Burkhardt, J. D., Santangeli, P., Mohanty, P., Sanchez, J. E., Horton, R., et al. (2014). Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation, 129(25), 2638\u20132644.","journal-title":"Circulation"},{"issue":"23","key":"126_CR18","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/CIRCULATIONAHA.109.921320","volume":"121","author":"L Biase Di","year":"2010","unstructured":"Di Biase, L., Burkhardt, J. D., Mohanty, P., Sanchez, J., Horton, R., Gallinghouse, G. J., et al. (2010). Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation, 121(23), 2550\u20132556.","journal-title":"Circulation"},{"issue":"5","key":"126_CR19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.hrthm.2014.03.003","volume":"11","author":"L Biase Di","year":"2014","unstructured":"Di Biase, L., Gaita, F., Toso, E., Santangeli, P., Mohanty, P., Rutledge, N., et al. (2014). Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study. Heart Rhythm, 11(5), 791\u2013798.","journal-title":"Heart Rhythm"},{"issue":"3","key":"126_CR20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1540-8167.2010.01894.x","volume":"22","author":"S Gautam","year":"2011","unstructured":"Gautam, S., John, R. M., Stevenson, W. G., Jain, R., Epstein, L. M., Tedrow, U., et al. (2011). Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 22(3), 248\u2013254.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"5","key":"126_CR21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/europace\/eur038","volume":"13","author":"A Hakalahti","year":"2011","unstructured":"Hakalahti, A., Uusimaa, P., Ylitalo, K., & Raatikainen, M. J. (2011). Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology, 13(5), 640\u2013645.","journal-title":"Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology"},{"issue":"5","key":"126_CR22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/jce.12069","volume":"24","author":"T Kuwahara","year":"2013","unstructured":"Kuwahara, T., Takahashi, A., Takahashi, Y., Kobori, A., Miyazaki, S., Takei, A., et al. (2013). Prevention of periprocedural ischemic stroke and management of hemorrhagic complications in atrial fibrillation ablation under continuous warfarin administration. Journal of Cardiovascular Electrophysiology, 24(5), 510\u2013515.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"6","key":"126_CR23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1540-8167.2009.01670.x","volume":"21","author":"JJ Kwak","year":"2010","unstructured":"Kwak, J. J., Pak, H. N., Jang, J. K., Kim, S. K., Park, J. H., Choi, J. I., et al. (2010). Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 21(6), 620\u2013625.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"3","key":"126_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1540-8167.2010.01910.x","volume":"22","author":"SP Page","year":"2011","unstructured":"Page, S. P., Siddiqui, M. S., Finlay, M., Hunter, R. J., Abrams, D. J., Dhinoja, M., et al. (2011). Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance? Journal of Cardiovascular Electrophysiology, 22(3), 265\u2013270.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"6","key":"126_CR25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jce.12411","volume":"25","author":"SP Page","year":"2014","unstructured":"Page, S. P., Herring, N., Hunter, R. J., Withycombe, E., Lovell, M., Wali, G., et al. (2014). Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin. Journal of Cardiovascular Electrophysiology, 25(6), 585\u2013590.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"4","key":"126_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0066-782X2011005000088","volume":"97","author":"EB Saad","year":"2011","unstructured":"Saad, E. B., Costa, I. P., Costa, R. E., Inacio, L. A., Jr., Slater, C., Camiletti, A., et al. (2011). Safety of ablation for atrial fibrillation with therapeutic INR: comparison with transition to low-molecular-weight heparin. Arquivos Brasileiros De Cardiologia, 97(4), 289\u2013296.","journal-title":"Arquivos Brasileiros De Cardiologia"},{"issue":"5","key":"126_CR27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/1755-5922.12082","volume":"32","author":"R Somani","year":"2014","unstructured":"Somani, R., Mohajer, K., Haley, C., Simpson, C. S., Abdollah, H., Baranchuk, A., et al. (2014). The peri-procedural use of dabigatran in patients undergoing left atrial ablation for atrial fibrillation. Cardiovascular Therapeutics, 32(5), 198\u2013201.","journal-title":"Cardiovascular Therapeutics"},{"issue":"2","key":"126_CR28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/14017431.2012.743674","volume":"47","author":"JM Tapanainen","year":"2013","unstructured":"Tapanainen, J. M., Braunschweig, F., Schwieler, J., Insulander, P., Bastani, H., Drca, N., et al. (2013). Continuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation. Scandinavian Cardiovascular Journal, 47(2), 109\u2013113.","journal-title":"Scandinavian Cardiovascular Journal"},{"issue":"22","key":"126_CR29","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/CIRCULATIONAHA.107.727784","volume":"116","author":"OM Wazni","year":"2007","unstructured":"Wazni, O. M., Beheiry, S., Fahmy, T., Barrett, C., Hao, S., Patel, D., et al. (2007). Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation, 116(22), 2531\u20132534.","journal-title":"Circulation"},{"issue":"6","key":"126_CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40261-013-0081-1","volume":"33","author":"H Yamaji","year":"2013","unstructured":"Yamaji, H., Murakami, T., Hina, K., Higashiya, S., Kawamura, H., Murakami, M., et al. (2013). Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation. Clinical Drug Investigation, 33(6), 409\u2013418.","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"126_CR31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1060028014563950","volume":"49","author":"HL Armbruster","year":"2015","unstructured":"Armbruster, H. L., Lindsley, J. P., Moranville, M. P., Habibi, M., Khurram, I. M., Spragg, D. D., et al. (2015). Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation. Annals of Pharmacotherapy, 49(3), 278\u2013284.","journal-title":"Annals of Pharmacotherapy"},{"issue":"3","key":"126_CR32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCEP.113.000320","volume":"6","author":"M Bassiouny","year":"2013","unstructured":"Bassiouny, M., Saliba, W., Rickard, J., Shao, M., Sey, A., Diab, M., et al. (2013). Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 6(3), 460\u2013466.","journal-title":"Circulation. Arrhythmia and Electrophysiology"},{"issue":"3","key":"126_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10840-013-9800-z","volume":"37","author":"DE Haines","year":"2013","unstructured":"Haines, D. E., Mead-Salley, M., Salazar, M., Marchlinski, F. E., Zado, E., Calkins, H., et al. (2013). Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 37(3), 233\u2013239.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"11","key":"126_CR34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/pace.12195","volume":"36","author":"H Ichiki","year":"2013","unstructured":"Ichiki, H., Oketani, N., Ishida, S., Iriki, Y., Okui, H., Maenosono, R., et al. (2013). The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran. Pacing and Clinical Electrophysiology, 36(11), 1328\u20131335.","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"3","key":"126_CR35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10840-013-9793-7","volume":"37","author":"DW Kaiser","year":"2013","unstructured":"Kaiser, D. W., Streur, M. M., Nagarakanti, R., Whalen, S. P., & Ellis, C. R. (2013). Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter. Journal of Interventional Cardiac Electrophysiology, 37(3), 241\u2013247.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"10","key":"126_CR36","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1253\/circj.CJ-12-0498","volume":"76","author":"K Kaseno","year":"2012","unstructured":"Kaseno, K., Naito, S., Nakamura, K., Sakamoto, T., Sasaki, T., Tsukada, N., et al. (2012). Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation. Circulation Journal, 76(10), 2337\u20132342.","journal-title":"Circulation Journal"},{"issue":"4","key":"126_CR37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hrthm.2012.12.011","volume":"10","author":"JS Kim","year":"2013","unstructured":"Kim, J. S., She, F., Jongnarangsin, K., Chugh, A., Latchamsetty, R., Ghanbari, H., et al. (2013). Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm, 10(4), 483\u2013489.","journal-title":"Heart Rhythm"},{"issue":"3","key":"126_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10840-012-9719-9","volume":"35","author":"SV Konduru","year":"2012","unstructured":"Konduru, S. V., Cheema, A. A., Jones, P., Li, Y., Ramza, B., & Wimmer, A. P. (2012). Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin. Journal of Interventional Cardiac Electrophysiology, 35(3), 277\u2013284.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"13","key":"126_CR39","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jacc.2011.12.014","volume":"59","author":"D Lakkireddy","year":"2012","unstructured":"Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vanga, S. R., Santangeli, P., Swarup, V., et al. (2012). Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. Journal of the American College of Cardiology, 59(13), 1168\u20131174.","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"126_CR40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/jce.12143","volume":"24","author":"W Maddox","year":"2013","unstructured":"Maddox, W., Kay, G. N., Yamada, T., Osorio, J., Doppalapudi, H., Plumb, V. J., et al. (2013). Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology, 24(8), 861\u2013865.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"10","key":"126_CR41","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2169\/internalmedicine.54.3520","volume":"54","author":"T Nagao","year":"2015","unstructured":"Nagao, T., Inden, Y., Shimano, M., Fujita, M., Yanagisawa, S., Kato, H., et al. (2015). Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation. Internal Medicine, 54(10), 1167\u20131173.","journal-title":"Internal Medicine"},{"issue":"9","key":"126_CR42","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.hrthm.2015.04.016","volume":"12","author":"T Nagao","year":"2015","unstructured":"Nagao, T., Inden, Y., Yanagisawa, S., Kato, H., Ishikawa, S., Okumura, S., et al. (2015). Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation. Heart Rhythm, 12(9), 1972\u20131978.","journal-title":"Heart Rhythm"},{"issue":"2","key":"126_CR43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/pace.12036","volume":"36","author":"T Nin","year":"2013","unstructured":"Nin, T., Sairaku, A., Yoshida, Y., Kamiya, H., Tatematsu, Y., Nanasato, M., et al. (2013). A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation. Pacing and Clinical Electrophysiology, 36(2), 172\u2013179.","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"1","key":"126_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10840-012-9708-z","volume":"35","author":"D Snipelisky","year":"2012","unstructured":"Snipelisky, D., Kauffman, C., Prussak, K., Johns, G., Venkatachalam, K., & Kusumoto, F. (2012). A comparison of bleeding complications post-ablation between warfarin and dabigatran. Journal of Interventional Cardiac Electrophysiology, 35(1), 29\u201333.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"1","key":"126_CR45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10840-014-9888-9","volume":"40","author":"G Stepanyan","year":"2014","unstructured":"Stepanyan, G., Badhwar, N., Lee, R. J., Marcus, G. M., Lee, B. K., Tseng, Z. H., et al. (2014). Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. Journal of Interventional Cardiac Electrophysiology, 40(1), 33\u201338.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"3","key":"126_CR46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10840-013-9801-y","volume":"37","author":"K Imamura","year":"2013","unstructured":"Imamura, K., Yoshida, A., Takei, A., Fukuzawa, K., Kiuchi, K., Takami, K., et al. (2013). Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay. Journal of Interventional Cardiac Electrophysiology, 37(3), 223\u2013231.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"12","key":"126_CR47","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.cjca.2014.09.018","volume":"30","author":"S Kochhauser","year":"2014","unstructured":"Kochhauser, S., Khaykin, Y., Beardsall, J., Juta, R., Hache, P., Trought, K., et al. (2014). Comparison of outcomes after cardioversion or atrial fibrillation ablation in patients with differing periprocedural anticoagulation regimens. Canadian Journal of Cardiology, 30(12), 1541\u20131546.","journal-title":"Canadian Journal of Cardiology"},{"issue":"28","key":"126_CR48","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","volume":"36","author":"R Cappato","year":"2015","unstructured":"Cappato, R., Marchlinski, F. E., Hohnloser, S. H., Naccarelli, G. V., Xiang, J., Wilber, D. J., et al. (2015). Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. European Heart Journal, 36(28), 1805\u20131811.","journal-title":"European Heart Journal"},{"issue":"4","key":"126_CR49","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCEP.114.001586","volume":"7","author":"R Dillier","year":"2014","unstructured":"Dillier, R., Ammar, S., Hessling, G., Kaess, B., Pavaci, H., Buiatti, A., et al. (2014). Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures. Circulation. Arrhythmia and Electrophysiology, 7(4), 576\u2013582.","journal-title":"Circulation. Arrhythmia and Electrophysiology"},{"issue":"10","key":"126_CR50","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2013.11.039","volume":"63","author":"D Lakkireddy","year":"2014","unstructured":"Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vallakati, A., Mansour, M. C., Santangeli, P., et al. (2014). Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. Journal of the American College of Cardiology, 63(10), 982\u2013988.","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"126_CR51","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.hrthm.2015.02.028","volume":"12","author":"L Biase Di","year":"2015","unstructured":"Di Biase, L., Lakkireddy, D., Trivedi, C., Deneke, T., Martinek, M., Mohanty, S., et al. (2015). Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study. Heart Rhythm, 12(6), 1162\u20131168.","journal-title":"Heart Rhythm"},{"issue":"1","key":"126_CR52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2014.10.005","volume":"115","author":"BM Kaess","year":"2015","unstructured":"Kaess, B. M., Ammar, S., Reents, T., Dillier, R., Lennerz, C., Semmler, V., et al. (2015). Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon. American Journal of Cardiology, 115(1), 47\u201351.","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"126_CR53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pace.12553","volume":"38","author":"T Nagao","year":"2015","unstructured":"Nagao, T., Inden, Y., Shimano, M., Fujita, M., Yanagisawa, S., Kato, H., et al. (2015). Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation. Pacing and Clinical Electrophysiology, 38(2), 155\u2013163.","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"11","key":"126_CR54","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40261-013-0134-5","volume":"33","author":"A Sairaku","year":"2013","unstructured":"Sairaku, A., Yoshida, Y., Ando, M., Hirayama, H., Nakano, Y., & Kihara, Y. (2013). A head-to-head comparison of periprocedural coagulability under anticoagulation with rivaroxaban versus dabigatran in patients undergoing ablation of atrial fibrillation. Clinical Drug Investigation, 33(11), 847\u2013853.","journal-title":"Clinical Drug Investigation"},{"issue":"4","key":"126_CR55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.amjcard.2014.05.038","volume":"114","author":"MR Aryal","year":"2014","unstructured":"Aryal, M. R., Ukaigwe, A., Pandit, A., Karmacharya, P., Pradhan, R., Mainali, N. R., et al. (2014). Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation. American Journal of Cardiology, 114(4), 577\u2013582.","journal-title":"American Journal of Cardiology"},{"key":"126_CR56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2015.03.102","volume":"185","author":"K Phan","year":"2015","unstructured":"Phan, K., Wang, N., Pison, L., Kumar, N., Hitos, K., & Thomas, S. P. (2015). Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: a meta-analysis. International Journal of Cardiology, 185, 209\u2013213.","journal-title":"International Journal of Cardiology"},{"issue":"104","key":"126_CR57","first-page":"193","volume":"19","author":"W Li","year":"2015","unstructured":"Li, W., Gao, C., Li, M., Wang, X., Qi, D., Zhang, Y., et al. (2015). Safety and efficacy of rivaroxaban versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a meta-analysis of observational studies. Discovery Medicine, 19(104), 193\u2013201.","journal-title":"Discovery Medicine"},{"issue":"10","key":"126_CR58","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/europace\/eut241","volume":"15","author":"SH Hohnloser","year":"2013","unstructured":"Hohnloser, S. H., & Camm, A. J. (2013). Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology, 15(10), 1407\u20131411.","journal-title":"Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology"},{"issue":"10","key":"126_CR59","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/europace\/eut239","volume":"15","author":"AA Bin Abdulhak","year":"2013","unstructured":"Bin Abdulhak, A. A., Khan, A. R., Tleyjeh, I. M., Spertus, J. A., Sanders, S. U., Steigerwalt, K. E., et al. (2013). Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology, 15(10), 1412\u20131420.","journal-title":"Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology"},{"issue":"4","key":"126_CR60","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/heartjnl-2013-304386","volume":"100","author":"R Providencia","year":"2014","unstructured":"Providencia, R., Albenque, J. P., Combes, S., Bouzeman, A., Casteigt, B., Combes, N., et al. (2014). Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Heart, 100(4), 324\u2013335.","journal-title":"Heart"},{"issue":"10","key":"126_CR61","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cjca.2013.07.005","volume":"29","author":"M Shurrab","year":"2013","unstructured":"Shurrab, M., Morillo, C. A., Schulman, S., Kansal, N., Danon, A., Newman, D., et al. (2013). Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis. Canadian Journal of Cardiology, 29(10), 1203\u20131210.","journal-title":"Canadian Journal of Cardiology"},{"issue":"3","key":"126_CR62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10840-013-9813-7","volume":"37","author":"BA Steinberg","year":"2013","unstructured":"Steinberg, B. A., Hasselblad, V., Atwater, B. D., Bahnson, T. D., Washam, J. B., Alexander, J. H., et al. (2013). Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies. Journal of Interventional Cardiac Electrophysiology, 37(3), 213\u2013221.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"7","key":"126_CR63","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.amjcard.2013.12.027","volume":"113","author":"P Sardar","year":"2014","unstructured":"Sardar, P., Nairooz, R., Chatterjee, S., Wetterslev, J., Ghosh, J., & Aronow, W. S. (2014). Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation. American Journal of Cardiology, 113(7), 1173\u20131177.","journal-title":"American Journal of Cardiology"},{"issue":"14","key":"126_CR64","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/sim.3594","volume":"28","author":"NJ Cooper","year":"2009","unstructured":"Cooper, N. J., Sutton, A. J., Morris, D., Ades, A. E., & Welton, N. J. (2009). Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Statistics in Medicine, 28(14), 1861\u20131881.","journal-title":"Statistics in Medicine"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-016-0126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-016-0126-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-016-0126-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:08:50Z","timestamp":1559254130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-016-0126-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1007\/s10840-016-0126-5","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}